Gynecologic Cancers in Canada
Author Information
Author(s): Duarte-Franco Eliane, Franco Eduardo L
Primary Institution: McGill University
Conclusion
There has been no significant improvement in survival rates for women with advanced endometrial or ovarian cancer in Canada over the past 30 years.
Supporting Evidence
- Cancers of the endometrium and ovaries account for 11% of all malignant neoplasms in women in Canada.
- Over 70% of ovarian cancer cases are diagnosed at late stages, leading to poor survival rates.
- Endometrial cancer has a generally favorable prognosis if diagnosed early, with a five-year survival rate of 75%.
Takeaway
Cancers of the uterus and ovaries are serious health issues for women in Canada, and many cases are diagnosed too late for effective treatment.
Methodology
Data on incidence and mortality rates were obtained from Statistics Canada and the SEER Program, along with published surveillance and research reports.
Limitations
Data on the efficacy of various screening strategies for gynecologic cancers are incomplete.
Participant Demographics
The report focuses on women in Canada, particularly those affected by gynecologic cancers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website